Headlands Technologies’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173K | Sell |
83,352
-9,206
| -10% | -$19.1K | 0.02% | 515 |
|
|
2025
Q1 | $204K | Buy |
92,558
+66,886
| +261% | +$147K | 0.02% | 456 |
|
|
2024
Q4 | $39.3K | Sell |
25,672
-24,024
| -48% | -$36.8K | ﹤0.01% | 849 |
|
|
2024
Q3 | $98.9K | Sell |
49,696
-40,799
| -45% | -$81.2K | 0.01% | 675 |
|
|
2024
Q2 | $317K | Buy |
90,495
+79,609
| +731% | +$279K | 0.03% | 375 |
|
|
2024
Q1 | $30.2K | Buy |
+10,886
| New | +$30.2K | 0.01% | 828 |
|
|
2023
Q3 | – | Sell |
-2,643
| Closed | -$3.07K | – | 1046 |
|
|
2023
Q2 | $3.07K | Buy |
+2,643
| New | +$3.07K | ﹤0.01% | 700 |
|